OLPX
Olaplex Holdings, Inc.1.4300
+0.1300+10%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
954.54MP/E (TTM)
-Basic EPS (TTM)
0.00Dividend Yield
0%Recent Filings
10-Q
8-K
8-K
Olaplex acquires Purvala for $10.5M
Olaplex closed its first-ever acquisition on August 20, 2025, buying Boston-based biotech Purvala Bioscience for $10.5 million, with $1.05 million held in escrow for 15 months. This move bolsters Olaplex's innovation pipeline by integrating Purvala's bioinspired technologies into its bond-building haircare lineup. Yet integration risks loom large. Forward-looking plans eye next-gen products.
8-K
Olaplex Q2 sales rise amid losses
Olaplex Holdings reported Q2 2025 net sales up 2.3% to $106.3 million, driven by 12.1% professional channel growth to $37.4 million and 12.8% direct-to-consumer rise to $38.5 million, yet specialty retail fell 16.7% to $30.4 million. Net loss hit $7.7 million versus $5.8 million income last year, with adjusted EBITDA dropping 23.4% to $24.6 million amid higher SG&A from litigation costs. The company repaid $300 million in debt on May 1, 2025, cutting long-term obligations to $351.9 million. Reaffirming 2025 guidance, Olaplex eyes high single-digit sales dip in Q3 but growth in Q4. Litigation drags profits.
10-Q
Q2 FY2025 results
Olaplex's Q2 net sales rose 2.3% y/y to $106.3M, fueled by 12.8% DTC growth and 12.1% professional channel gains, yet specialty retail fell 16.7% amid discounting pressures. Gross margin expanded to 71.2% from 69.7%, but SG&A surged 45.1% to $65.9M on marketing and legal costs, flipping operating income to a $1.2M loss from $16.3M profit; net loss hit $7.7M or $(0.01) per diluted share, reconciling to 666M shares with anti-dilution from options/RSUs. YTD sales edged up 0.2% to $203.3M, with operating income at $7.3M but net loss of $7.3M after $26.1M interest. Cash dropped to $289.3M post-$300M term loan repayment, leaving $351.9M debt at 7.9% and $150M revolver availability; FCF stood at $16.7M (derived). A $47.5M Lilien settlement accrual awaits insurance recovery. Competition in prestige haircare remains fierce.
BARK
BARK, Inc.
0.65+0.02
BBWI
Bath & Body Works, Inc.
19.64-0.08
EL
Estee Lauder Companies, Inc. (T
104.39+3.36
LESL
Leslie's, Inc.
2.18-0.03
ODP
The ODP Corporation
28.00+0.00
PSPX
PACIFIC SPORTS EXCHANGE INC.
1.00+0.00
SBH
Sally Beauty Holdings, Inc. (Na
14.90-0.01
TKLF
Tokyo Lifestyle Co., Ltd.
2.46-0.09
ULTA
Ulta Beauty, Inc.
589.27-1.93
XPEL
XPEL, Inc.
50.05-0.17